These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32691849)

  • 21. Prevalence and severity of ocular involvement in Graves' disease according to sex and age: A clinical study from Babol, Iran.
    Gharib S; Moazezi Z; Bayani MA
    Caspian J Intern Med; 2018; 9(2):178-183. PubMed ID: 29732037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
    Stan MN; Algeciras-Schimnich A; Murthy V; Thapa P; Araki N
    Thyroid; 2022 Feb; 32(2):170-176. PubMed ID: 34714163
    [No Abstract]   [Full Text] [Related]  

  • 23. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin.
    Tellez M; Cooper J; Edmonds C
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):291-4. PubMed ID: 1563082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid-associated ophthalmopathy in juvenile Graves' disease--clinical, endocrine and therapeutic aspects.
    Krassas GE; Gogakos A
    J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1193-206. PubMed ID: 17172081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.
    Cockerham KP; Padnick-Silver L; Stuertz N; Francis-Sedlak M; Holt RJ
    Ophthalmol Ther; 2021 Dec; 10(4):975-987. PubMed ID: 34478126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future Projections in Thyroid Eye Disease.
    Barbesino G; Salvi M; Freitag SK
    J Clin Endocrinol Metab; 2022 Aug; 107(Suppl_1):S47-S56. PubMed ID: 36346684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
    Wall JR; Lahooti H
    Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cigarette smoking and thyroid eye disease: a systematic review.
    Thornton J; Kelly SP; Harrison RA; Edwards R
    Eye (Lond); 2007 Sep; 21(9):1135-45. PubMed ID: 16980921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
    Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010576. PubMed ID: 26606533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
    Wall JR; Lahooti H
    Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.
    Yu CY; Ford RL; Wester ST; Shriver EM
    Indian J Ophthalmol; 2022 Jul; 70(7):2335-2345. PubMed ID: 35791115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.
    Gong J; Jiang SJ; Wang DK; Dong H; Chen G; Fang K; Cui JR; Lu FE
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):473-479. PubMed ID: 27465319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ophthalmic complications in juvenile Graves' Disease - clinic and therapeutic approaches.
    Krassas GE
    Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():223-9; discussion 229. PubMed ID: 16444162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of soluble Fas in patients with Graves' ophthalmopathy.
    Ohtsuka K; Hashimoto M
    Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography.
    Volpe NJ; Sbarbaro JA; Gendron Livingston K; Galetta SL; Liu GT; Balcer LJ
    Am J Ophthalmol; 2006 Jul; 142(1):75-81. PubMed ID: 16815253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral versus unilateral thyroid eye disease.
    Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
    Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower lid retraction in thyroid orbitopathy: lamellar shortening or proptosis?
    Rajabi MT; Jafari H; Mazloumi M; Tabatabaie SZ; Rajabi MB; Hasanlou N; Abtahi SM; Goldberg RA
    Int Ophthalmol; 2014 Aug; 34(4):801-4. PubMed ID: 24292849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy.
    Edmunds MR; Mellington F; Ford RL; Torlinska B; Manavi K; Boelaert K
    J Clin Endocrinol Metab; 2015 Mar; 100(3):779-87. PubMed ID: 25584718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.